Choosing Wisely Statins
Open Access
- 27 November 2020
- journal article
- editorial
- Published by Archives of Endocrinology and Metabolism in Archives of Endocrinology and Metabolism
- Vol. 64 (6) , 637-638
Abstract
Choosing Wisely is an initiative by the American Board of Internal Medicine (ABIM) “that seeks to advance a national dialogue on avoiding unnecessary medical tests, treatments and procedures” (2). In line with the initiative, Borges and cols. published an interesting review in this edition of the Archives of Endocrinology and Metabolism with the aim of rationalizing statin treatment to reduce side effects and improve adherence (3). However, how simple is it to choose statins wisely for individual patients? Should the decision be based on evidence, efficacy, or safety?Keywords
This publication has 5 references indexed in Scilit:
- Choosing statins: a review to guide clinical practiceArchives of Endocrinology and Metabolism, 2020
- Lipid profile and response to statin therapy in patients with hypopituitarismArchives of Endocrinology and Metabolism, 2020
- Effect of different types of statins on kidney function decline and proteinuria: a network meta-analysisScientific Reports, 2019
- Effects of Statins on Renal Outcome in Chronic Kidney Disease Patients: A Systematic Review and Meta-AnalysisPLOS ONE, 2015
- Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010The Lancet, 2012